GlassScriptPhysician profile
Manuel A Gurule
NPI 1235297839
$9,156.31
in general payments reported to CMS, 2019-2025
49 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $1,840 · 2021: $2,164 · 2022: $1,543 · 2023: $937 · 2024: $1,021 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,809.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,594.40 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $787.13 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Sunovion Pharmaceuticals INC. | $593.44 | 2019-2021 | |
| Lilly USA, LLC | $563.19 | 2019-2025 | Reyvow, Emgality, Amyvid |
| Ucb, INC. | $561.51 | 2019-2025 | Rystiggo, Fintepla |
| Amgen INC. | $523.79 | 2019-2025 | Aimovig, Uplizna |
| Novartis Pharmaceuticals Corporation | $490.52 | 2019-2023 | |
| Neurelis, INC. | $369.18 | 2020-2025 | Valtoco |
| Allergan, INC. | $335.17 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $277.51 | 2019-2025 | Ultomiris |
| Lundbeck LLC | $235.31 | 2020-2025 | Vyepti, Rexulti |
| Impel Pharmaceuticals INC. | $227.90 | 2022-2023 | Trudhesa |
| Emd Serono, INC. | $213.40 | 2020-2024 | Mavenclad |
| Biohaven Pharmaceuticals, INC. | $210.35 | 2020-2021 | |
| Eisai INC. | $172.23 | 2021-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Gurule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.